No down-side to starting durvalumab immediately after chemoradiation for unresectable stage III non-small cell lung cancer—some answers but more questions
Year: 2025
Type: article
Source: Journal of Thoracic Disease
DOI: 10.21037/jtd-24-1858
Authors: Oliver S. Chow, Nasser K. Altorki
Institutions: NewYork–Presbyterian Hospital, Weill Cornell Medicine
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4408034704
